Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
This paper introduces a novel framework for data fusion that combines small randomized controlled trials (RCTs) with large observational studies (OBS) to improve treatment effect estimation. The approach preserves the unbiasedness of RCTs while leveraging the statistical power of OBS without requiring strong assumptions on the observational data's confounding structure. The authors develop specific estimators for both average and conditional treatment effects, demonstrating their efficacy through experiments.
Large observational studies can finally boost the precision of small RCTs for treatment effect estimation without sacrificing unbiasedness or making strong confounding assumptions.
Randomized controlled trials (RCTs) identify treatment effects without confounding but are often small, whereas observational studies (OBS) are large but may be confounded. Many estimators combining a small RCT with a large OBS have been developed for the average treatment effect (ATE) and the conditional ATE (CATE). However, existing ATE estimators either make assumptions on the OBS or do not borrow enough power from them. The CATE has been studied less than the ATE. Existing CATE methods either assume the OBS are unconfounded, rely on a model of the confounding function, or accept bias in exchange for lower variance. We therefore propose a framework that, without special assumptions on the OBS, fuses the OBS and the RCT by preserving the unbiasedness of RCT-based estimation while borrowing power from the large OBS to boost precision. Applying this principle, we build an ATE estimator, AIPW-Fusion, with closed-form weights and confidence intervals, and two CATE learners, DR-Fusion and R-Fusion. Experiments corroborate our findings.